As of May 28, 2025, Ramsay Generale de Sante SA (GDS.PA) reports a Gross Margin of 78.75%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Ramsay Generale de Sante SA's Gross Margin
Over recent years, Ramsay Generale de Sante SA's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-06-30 | 78.75% |
| 2023-06-30 | 79.18% |
| 2022-06-30 | 79.29% |
| 2021-06-30 | 79.65% |
| 2020-06-30 | 80.47% |
This gradual decrease highlights how Ramsay Generale de Sante SA manages its operational efficiency and pricing power over time.
Comparing Ramsay Generale de Sante SA's Gross Margin to Peers
To better understand Ramsay Generale de Sante SA's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Ramsay Generale de Sante SA (GDS.PA) | 78.75% |
| Ambea AB (publ) (AMBEA.ST) | 96.53% |
| Korian SE (KORI.PA) | 92.07% |
| Humana AB (HUM.ST) | 88.51% |
| Clinica Baviera SA (CBAV.MC) | 88.36% |
| EMC Instytut Medyczny SA (EMC.WA) | 87.63% |
Compared to its competitors, Ramsay Generale de Sante SA's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.